{"id":40344,"date":"2025-08-29T13:17:55","date_gmt":"2025-08-29T05:17:55","guid":{"rendered":"https:\/\/flcube.com\/?p=40344"},"modified":"2025-08-29T13:17:55","modified_gmt":"2025-08-29T05:17:55","slug":"zennova-rapafusyn-forge-biocarier%e2%80%91powered-rapaglue-collaboration-2025","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=40344","title":{"rendered":"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025"},"content":{"rendered":"\n<p>Zennova Pharmaceuticals Group and Rapafusyn Pharmaceuticals on Aug. 28, 2025 announced a strategic collaboration to jointly develop Rapafusyn\u2019s RapaGlue molecular\u2011glue candidate, RAP\u20118020, and other pipeline molecules. Zennova will leverage its proprietary BioCarier technology platform to optimize drug\u2011delivery systems for Rapafusyn\u2019s candidates.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-partnership-overview\">Strategic Partnership Overview<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Joint Development<\/strong>: Focus on RAP\u20118020, a next\u2011generation molecular glue drug.<\/li>\n\n\n\n<li><strong>Technology Leveraged<\/strong>: BioCarier, Zennova\u2019s core platform for targeted delivery and controlled release.<\/li>\n\n\n\n<li><strong>Scope<\/strong>: Immunology\u2011oncology targets, pain therapeutics, and kidney disease.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-target-portfolio\">Target Portfolio<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Therapeutic Domain<\/th><th>Specific Targets<\/th><th>Clinical Rationale<\/th><\/tr><\/thead><tbody><tr><td><strong>Immunology<\/strong><\/td><td>TNF\u03b1R1 pathway<\/td><td>Reduces inflammation in autoimmune disorders with high unmet need.<\/td><\/tr><tr><td><\/td><td>STAT6 transcription factor<\/td><td>Modulates allergic and atopic responses.<\/td><\/tr><tr><td><strong>Oncology<\/strong><\/td><td>Myc\u2011driven tumors<\/td><td>Inhibits oncogenic transcription factor overexpressed in many cancers.<\/td><\/tr><tr><td><\/td><td>Cancer\u2011cell ferroptosis<\/td><td>Induces iron\u2011dependent cell death in resistant tumor cells.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-future-expansion-plans\">Future Expansion Plans<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Pain (Non\u2011Opioid Analgesics)<\/strong> \u2013 Explores FKBP12\u2011target protein regulation to deliver novel, opioid\u2011free pain relief.<\/li>\n\n\n\n<li><strong>Kidney Disease<\/strong> \u2013 Applies BioCarier\u2011mediated delivery to modulate renal cellular pathways implicated in chronic kidney disease.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-commercial-outlook\">Commercial Outlook<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>First\u2011to\u2011Market Advantage<\/strong>: RapaGlue\u2019s unique mechanism positions it ahead of conventional biologics.<\/li>\n\n\n\n<li><strong>Regulatory Pathway<\/strong>: Early engagement with regulatory bodies in China and the U.S. to streamline approval.<\/li>\n\n\n\n<li><strong>Pipeline Synergy<\/strong>: Shared expertise accelerates candidate progression from pre\u2011clinical to clinical stages.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zennova Pharmaceuticals Group and Rapafusyn Pharmaceuticals on Aug. 28, 2025 announced a strategic collaboration to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":40346,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4320,70,2504],"class_list":["post-40344","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-rapafusyn-pharmaceuticals","tag-tpd","tag-zennova-pharmaceutical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025 - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2011based Zennova Pharmaceuticals Group partners with U.S. Rapafusyn to develop RapaGlue (RAP\u20118020) using Zennova\u2019s BioCarier platform. The alliance targets TNF\u03b1R1\u2011related immunologic diseases, STAT6, Myc\u2011driven cancers, ferroptosis\u2011based tumors, and plans future expansion into non\u2011opioid pain and kidney disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=40344\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025\" \/>\n<meta property=\"og:description\" content=\"China\u2011based Zennova Pharmaceuticals Group partners with U.S. Rapafusyn to develop RapaGlue (RAP\u20118020) using Zennova\u2019s BioCarier platform. The alliance targets TNF\u03b1R1\u2011related immunologic diseases, STAT6, Myc\u2011driven cancers, ferroptosis\u2011based tumors, and plans future expansion into non\u2011opioid pain and kidney disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=40344\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T05:17:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025\",\"datePublished\":\"2025-08-29T05:17:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344\"},\"wordCount\":224,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2902.webp\",\"keywords\":[\"Rapafusyn Pharmaceuticals\",\"TPD\",\"Zennova Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40344#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=40344\",\"name\":\"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025 - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2902.webp\",\"datePublished\":\"2025-08-29T05:17:55+00:00\",\"description\":\"China\u2011based Zennova Pharmaceuticals Group partners with U.S. Rapafusyn to develop RapaGlue (RAP\u20118020) using Zennova\u2019s BioCarier platform. The alliance targets TNF\u03b1R1\u2011related immunologic diseases, STAT6, Myc\u2011driven cancers, ferroptosis\u2011based tumors, and plans future expansion into non\u2011opioid pain and kidney disease.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40344\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2902.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2902.webp\",\"width\":1080,\"height\":608,\"caption\":\"Zennova & Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40344#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025 - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2011based Zennova Pharmaceuticals Group partners with U.S. Rapafusyn to develop RapaGlue (RAP\u20118020) using Zennova\u2019s BioCarier platform. The alliance targets TNF\u03b1R1\u2011related immunologic diseases, STAT6, Myc\u2011driven cancers, ferroptosis\u2011based tumors, and plans future expansion into non\u2011opioid pain and kidney disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=40344","og_locale":"en_US","og_type":"article","og_title":"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025","og_description":"China\u2011based Zennova Pharmaceuticals Group partners with U.S. Rapafusyn to develop RapaGlue (RAP\u20118020) using Zennova\u2019s BioCarier platform. The alliance targets TNF\u03b1R1\u2011related immunologic diseases, STAT6, Myc\u2011driven cancers, ferroptosis\u2011based tumors, and plans future expansion into non\u2011opioid pain and kidney disease.","og_url":"https:\/\/flcube.com\/?p=40344","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-08-29T05:17:55+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=40344#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=40344"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025","datePublished":"2025-08-29T05:17:55+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=40344"},"wordCount":224,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=40344#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp","keywords":["Rapafusyn Pharmaceuticals","TPD","Zennova Pharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=40344#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=40344","url":"https:\/\/flcube.com\/?p=40344","name":"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025 - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=40344#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=40344#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp","datePublished":"2025-08-29T05:17:55+00:00","description":"China\u2011based Zennova Pharmaceuticals Group partners with U.S. Rapafusyn to develop RapaGlue (RAP\u20118020) using Zennova\u2019s BioCarier platform. The alliance targets TNF\u03b1R1\u2011related immunologic diseases, STAT6, Myc\u2011driven cancers, ferroptosis\u2011based tumors, and plans future expansion into non\u2011opioid pain and kidney disease.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=40344#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=40344"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=40344#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp","width":1080,"height":608,"caption":"Zennova & Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=40344#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Zennova &amp; Rapafusyn Forge BioCarier\u2011Powered RapaGlue Collaboration \u2013 2025"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2902.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40344"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40344\/revisions"}],"predecessor-version":[{"id":40347,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40344\/revisions\/40347"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/40346"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}